Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.
about
Soluble recombinant influenza vaccines.Mechanisms of Cross-protection by Influenza Virus M2-based VaccinesM2e-Based Universal Influenza A VaccinesPolarizing T and B Cell Responses by APC-Targeted Subunit VaccinesVirus-like particles as antigenic nanomaterials for inducing protective immune responses in the lungTowards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingImmunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellinMicroneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunityNew vaccines against influenza virus.Advances in influenza vaccination.Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.Heterosubtypic immunity to influenza A virus: where do we stand?Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsEvolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis.A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza VirusCross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.Novel vaccines against influenza viruses.Targets for the induction of protective immunity against influenza a viruses.Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designVirus-like particles as universal influenza vaccinesPrior infection of chickens with H1N1 or H1N2 avian influenza elicits partial heterologous protection against highly pathogenic H5N1.The prospects and challenges of universal vaccines for influenzaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferretProphylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunityInfluenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cellsIntranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinHuman monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in miceProtection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
P2860
Q24522388-01F06241-9458-493F-AD02-B1899D8EC69CQ26777740-346F2B71-0414-487D-84D5-F9C3F3AF6A60Q26783493-99DD224E-CB9C-4EA3-90E3-C251726A343EQ26800145-78EF829A-0099-40F7-BF15-92DB79F74682Q26825031-F4F4BCA4-884F-479F-AD14-995204527A2DQ27003874-2C7CFC3F-DAEC-4B6F-A369-2BE840914633Q28743939-C21B5005-FFBB-4A1A-ADE9-272C44FCE3A2Q30357830-F550C57C-5CA0-4CAD-9A52-908C040ABF79Q30357932-2762F4F3-A1D3-42B6-8520-3272707CB5D9Q30364315-C36F644D-E362-4F11-8EA8-BEDC52246C24Q30368359-66604FEF-B8D0-43BD-96A5-3B576E8FB8FBQ30370995-70C21423-4665-4E98-9693-2CBAEB132739Q30375991-311628FE-CCD4-42C9-B63D-7AD4A842B0C3Q30376292-61B6BBB7-2EFE-472F-99D1-D86C97BBA0FAQ30377641-94103F20-6BAB-4FFC-964B-AE7F2B181331Q30384304-7B899ECE-39B7-47C2-A0E7-B423EC36BF8FQ30389407-1E589707-26D4-4D56-8B33-62C5EC5B5564Q30391221-763DB8BE-A554-49B3-B14F-A09D23AF1402Q30407716-FD764BAB-D7DC-4F8D-8ACB-FFF3E132515BQ30408100-85061D30-1247-4F8A-83FA-1C251356941BQ30410241-CD0B6EF6-67FD-4F0A-8058-C936AEC7505AQ30416502-C058F5E8-DFC7-4C9E-8233-79AB71DD641CQ30421558-024347E4-A5D2-4E00-87A4-3ABD1EDA5D0CQ30424773-EF4D03A1-14A4-4833-B7A1-759D4B1409D0Q30430703-A9B7DE4A-61CF-4B99-B758-3D09A0A599EEQ33419836-179A57B8-64A6-4469-A44E-A43CFD3329A1Q33547457-5BA80104-697A-489E-B9EF-AD90900C4E28Q33582945-70883296-2CA4-4E72-A5E1-1025FF504094Q33648987-E032500B-A1F0-4E5E-BE83-2B3BDEEB6588Q33788879-47E53E45-EEF9-425F-9F4C-800321A009F4Q33936440-ACB0BB61-40F0-4FE4-BA0A-8AEEB7E38191Q34059627-572E1C25-782E-46FB-AB13-73A4E8885C1FQ34099149-70A71747-47DD-4E28-A8EE-FC2E20C77FEBQ34105207-09C92981-8399-474F-86BA-CFF30AF68E31Q34430020-F29B5B29-D498-4A88-87EA-91913F5D2796Q34629573-92F17161-A61C-4D88-BFD6-D99EED51F2E8Q34721639-680B83E0-BC84-44DE-A977-054D55415AF2Q34971370-EEFD9737-B283-4750-B66C-115608AEBC87Q35209148-304CA509-7B1E-49EA-91D6-D5241CB51681Q35606494-11E81D03-6465-4CC8-9D7B-5792FA37F40D
P2860
Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Passively transferred monoclon ...... a A virus replication in mice.
@ast
Passively transferred monoclon ...... a A virus replication in mice.
@en
type
label
Passively transferred monoclon ...... a A virus replication in mice.
@ast
Passively transferred monoclon ...... a A virus replication in mice.
@en
prefLabel
Passively transferred monoclon ...... a A virus replication in mice.
@ast
Passively transferred monoclon ...... a A virus replication in mice.
@en
P2093
P2860
P1433
P1476
Passively transferred monoclon ...... a A virus replication in mice.
@en
P2093
B R Murphy
E L Tierney
J J Treanor
S L Zebedee
P2860
P304
P407
P577
1990-03-01T00:00:00Z